ADVERTISEMENT
ADVERTISEMENT
A vial labeled “RSV vaccine” on a reflective surface next to a syringe and stethoscope.
After Decades of Delays, RSV Vaccines Show Promise in Early Data 
Both Pfizer and GSK have shared preliminary data suggesting that their experimental vaccines can protect older adults and newborn infants from the virus.
After Decades of Delays, RSV Vaccines Show Promise in Early Data 
After Decades of Delays, RSV Vaccines Show Promise in Early Data 

Both Pfizer and GSK have shared preliminary data suggesting that their experimental vaccines can protect older adults and newborn infants from the virus.

Both Pfizer and GSK have shared preliminary data suggesting that their experimental vaccines can protect older adults and newborn infants from the virus.

  1. Home
  2. Subjects
  3. GSK
GSK
Layoffs, Restructuring at GSK
Tracy Vence | Dec 4, 2014 | 1 min read
GlaxoSmithKline is eliminating 900 US jobs—most in R&D.
Ebola Vaccine Candidate Shows Promise
Molly Sharlach | Dec 1, 2014 | 2 min read
An experimental Ebola vaccine developed by the US National Institutes of Health appears to be safe and effective, according to a small, early-stage clinical trial.
Novartis and Glaxo Agree to Big Deal
Bob Grant | Apr 22, 2014 | 1 min read
The pharmaceutical companies announce a suite of asset swaps that drove up share prices and will reshape both.
Scandalous GSK Paper Retracted
Bob Grant | Dec 10, 2013 | 2 min read
The publication at the center of a June controversy for drugmaker GlaxoSmithKline is finally pulled from the literature.
Top GSK Scientist Fired Over Paper
Bob Grant | Jun 19, 2013 | 2 min read
The head of GlaxoSmithKline’s Shanghai neurodegenerative-disease research unit is axed after irregularities are uncovered in a 2010 paper he published.
ADVERTISEMENT
ADVERTISEMENT